Overview
Explore a comprehensive range of theranostics and radionuclide therapy solutions designed to support the full treatment pathway-from patient preparation and radiopharmaceutical administration to dosimetry, treatment monitoring, radiation safety, and post-therapy imaging. The portfolio includes radionuclide therapy infrastructure for applications such as Lu-177, I-131, Y-90, Ra-223, and other therapeutic radionuclides, together with patient administration systems, therapy rooms, shielding, contamination-control solutions, waste-management systems, dosimetry support, post-therapy imaging technologies, and related clinical accessories. These solutions are intended to support safe treatment delivery, personalized therapy planning, accurate dose assessment, efficient clinical workflows, and the development of modern theranostics programs.
